OptiPin
SLU-PP-332: uses, dosing & the facts
A research compound that activates the ERRα (estrogen-related receptor alpha) pathway, potentially enhancing muscle endurance, strength, and metabolic function. This is an evidence-graded reference – what it is, what it's used for, typical reported dosing, half-life, side effects, and how to track it. It is educational, not medical advice or a recommendation to use a research compound.
- • SLU-PP-332 – Fat loss. A research compound that activates the ERRα (estrogen-related receptor alpha) pathway, potentially enhancing muscle endurance, strength, and metabolic function.
- • Commonly used for muscle endurance enhancement, strength and performance, metabolic function support.
- • Half-life: Approximately 4–6 hours.
- • Status: Research use only · not FDA-approved – an educational reference, not a dose protocol or sourcing advice.
What SLU-PP-332 is
A research compound that activates the ERRα (estrogen-related receptor alpha) pathway, potentially enhancing muscle endurance, strength, and metabolic function.
What SLU-PP-332 is used for
- • Muscle endurance enhancement
- • Strength and performance
- • Metabolic function support
- • Exercise capacity improvement
- • Athletic performance
- • Body recomposition
These are reported/community uses, not proven clinical outcomes. Most research peptides have limited human trial data behind such claims.
Typical reported dosing
| Oral | 100–500mcg taken orally daily, typically 1–2 hours before training |
Presented as commonly-reported patterns for information only – not a dose recommendation. SLU-PP-332 dosing is a decision for a qualified clinician.
Half-life & cycling
Half-life: Approximately 4–6 hours. Half-life drives dosing frequency and how quickly the compound clears – see it plotted on the SLU-PP-332 half-life calculator.
Cycling
Can be used continuously during training periods. Typical cycles: 8–12 weeks on, 4 weeks off.
Side effects & warnings
- an injection site that turns red, hot or hard, spreads, weeps, or comes with a fever – same-day medical care – research-grade material carries no sterility guarantee, so abscess and cellulitis are the documented consequence
- swelling of the lips, tongue or throat, trouble breathing, or widespread hives after a dose – emergency care
- severe abdominal pain that bores through to the back and does not settle – urgent assessment for pancreatitis
- vomiting that stops you keeping fluids down – urgent care – dehydration is the common reason people on these compounds are admitted
- shaking, sweating, confusion or a racing heart, especially alongside insulin or a sulfonylurea – treat for low blood sugar and seek advice
- • Generally well-tolerated
- • Limited safety data available
- • Possible mild gastrointestinal effects
Research use only. Very new research compound. Limited human data available. Oral administration is convenient. May enhance exercise performance. Start with lower doses. Take before workouts for best results. Not technically a peptide but often grouped with research peptides.
Tracking SLU-PP-332 in OptiPin
If you're tracking a SLU-PP-332 protocol, OptiPin logs each dose with reminders and site rotation, charts the outcome you care about over your dose timeline, keeps per-vial inventory with runout warnings, and (where relevant) does the reconstitution math – all on-device, no account.
Log doses, outcomes & vials in OptiPin
Reminders, outcome-over-dose charts, vial runout warnings, and built-in reconstitution math – all on-device.
Download on the App StoreFAQ
What is SLU-PP-332?
A research compound that activates the ERRα (estrogen-related receptor alpha) pathway, potentially enhancing muscle endurance, strength, and metabolic function.
What is SLU-PP-332 used for?
Commonly discussed uses include: muscle endurance enhancement, strength and performance, metabolic function support, exercise capacity improvement, athletic performance, body recomposition. These are reported uses, not proven outcomes or a recommendation.
How is SLU-PP-332 dosed?
Commonly reported dosing: Oral – 100–500mcg taken orally daily, typically 1–2 hours before training. This reflects patterns discussed in the community and is presented for information only, not as a dose recommendation – SLU-PP-332 is not an approved medicine and dosing should involve a qualified clinician.
What is SLU-PP-332's half-life?
Approximately 4–6 hours. Half-life shapes how often it is dosed and how quickly it clears.
What are SLU-PP-332's side effects?
Reported effects include: generally well-tolerated, limited safety data available, possible mild gastrointestinal effects. Because it is a research compound, its safety profile is not fully characterized; discuss risks with a clinician.
Evidence & further reading
- Search the peer-reviewed literature for SLU-PP-332 on PubMed (entry point to the primary evidence base, not a specific citation).
- SLU-PP-332 on ClinicalTrials.gov – registered human trials, if any.
- US FDA / 503A compounding status of research peptides (2026).
- OptiPin peptides guide – categories, evidence grading, and how to run a protocol honestly.
Related
Tesofensine · 5-Amino-1MQ · AOD-9604 · BAM-15 · Tirzepatide (Mounjaro/Zepbound) · Reconstitution calculator · All peptides